Chemours Shares Tumble as Q4 Loss Widens on Inventory Charges

The Wilmington-based company reported a net loss of 31 cents per share, a sharp decline from the 8-cent loss recorded during the same period last year. On an adjusted basis, earnings reached 5 cents per share, failing to meet the 7-cent consensus estimate from analysts polled by FactSet. The sell-off follows a period of significant growth for the stock, which had climbed 73% year-to-date as of Thursday’s close.

Market Headwinds and Inventory Hits

Chief Executive Denise Dignam linked the quarterly performance to a "tepid" macroeconomic environment that has specifically pressured the company’s Advanced Performance Materials division. According to the report, these challenges necessitated a sizable non-cash inventory charge and led to an unfavorable product mix that weighed heavily on the bottom line.

Despite the immediate fiscal pressure, leadership expressed confidence in the company's long-term trajectory. Dignam stated that while short-term conditions remain difficult, Chemours expects to achieve significant cash generation by 2026.

The following figures highlight the quarter's impact:

• Premarket stock decline of 9.9% to $18.39.
• Adjusted earnings of 5 cents per share against a 7-cent estimate.
• A GAAP net loss of 31 cents per share compared to 8 cents year-over-year.